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BACKGROUND: It has been reported that although young patients present with more advanced disease, when adjusted for stage,
cancer-specific survival is not different after surgery for colorectal cancer. However, few studies have examined non-cancer survival in
young patients and 10-year survival has rarely been reported. Moreover, the largest study included patients of old age as a
comparator. The aim of this study was to compare cancer-specific and non-cancer-related survival at 10 years in a young age cohort
and a middle age cohort in patients undergoing surgery for colorectal cancer.
METHODS: Two thousand and seventy seven patients who underwent surgery for colorectal cancer between 1991 and 1994 in
11 hospitals in Scotland were included in the study. Ten-year cancer-specific and non-cancer-related survival and the hazard ratios
(HR) were calculated according to age groups (o45/45–54/55–64/65–74 years).
RESULTS: On follow-up, 1066 patients died of their cancer and 369 died of non-cancer-related causes. At 10 years, overall survival was
32%, cancer-specific was 45%, and non-cancer-related survival was 72%. On multivariate analysis of all factors, sex (HR 0.77, 95% CI
0.68–0.88, Po0.001), mode of presentation (HR 1.64, 95% CI 1.44–1.87, Po0.01), Dukes’ stage (HR 2.69, 95% CI 2.49–2.90,
Po0.001), and specialisation (HR 1.24, 95% CI 1.04–1.44, Po0.01) were independently associated with cancer-specific survival.
On multivariate analysis of all factors, age (HR 2.46, 2.04–2.97, Po0.001), sex (HR 0.56, 0.45–0.70, Po0.001), and deprivation
(HR 1.16, 1.10–1.24, Po0.001) were independently associated with non-cancer-related survival.
CONCLUSION: The results of this study confirm that young age does not have a negative impact on cancer-specific survival. Moreover,
they show that, with 10-year follow-up, young age does not have a negative impact on non-cancer-related survival.
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Colorectal cancer is the second commonest cause of cancer
death in Western Europe and North America. Many patients have
evidence of locally advanced or metastatic disease at the time of
initial presentation. Even in those undergoing apparently curative
resection, only half survive for 5 years (McArdle and Hole, 2002).
There are a number of factors, in addition to pathological stage,
which influence the outcome after surgery for colorectal cancer.
These include male gender, deprivation, emergency presentation,
and specialisation (McArdle and Hole, 2002).
There is also evidence that old age has a negative impact on
5-year cancer-specific survival after resection for colorectal
cancer (Shankar and Taylor, 1998; Colorectal Cancer Collaborative
Group, 2000). Furthermore, with 10-year follow-up, the impact
of old age appears greater in non-cancer-related compared with
cancer-specific survival (McMillan et al, 2008).
The impact of young age on cancer-specific and non-cancer-
related survival after potentially curative resection is less clear.
A number of studies have reported that young patients had similar
cancer-specific survival compared with other patients (Bu ¨low,
1980; Ja ¨rvinen and Turunen, 1984; Isbister and Fraser, 1990;
Cusack et al, 1996; Chung et al, 1998; O’Connell et al, 2004;
Endreseth et al, 2006; Quah et al, 2007). However, these studies
had limited follow-up and did not report the effect of young age on
non-cancer-related survival.
In the largest study to date, O’Connell et al (2004) analysed the
SEER national cancer database and identified two cohorts based
on age. A young cohort consisting of 1334 patients aged between
20 and 40 years was compared with an old cohort consisting of
46457 patients aged between 60 and 80 years for cancer-specific
and non-cancer-related survival. They reported that young
patients presented with more advanced disease but had similar
cancer-specific survival compared with the old age cohort.
However, old age patients have different cancer-specific and
non-cancer-related outcomes compared with the majority of
patients, who are middle aged. Indeed, it has been reported that
there is an approximate two-fold reduction in cancer-specific
survival and a five-fold reduction in non-cancer-related survival in
the old age cohort (McMillan et al, 2008). Therefore, their previous
comparison of young age cohort with an old age cohort may have
been inappropriate (O’Connell et al, 2004). Moreover, their follow-
up was limited to 5 years and they did not examine the effect of Received 18 February 2009; revised 15 June 2009; accepted 3 July 2009
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syoung age on non-cancer-related survival in patients undergoing
surgery for colorectal cancer.
The aim of this study was to compare cancer-specific and non-
cancer-related survival at 10 years in a young age cohort and a
middle age cohort in patients undergoing surgery for colorectal
cancer.
MATERIALS AND METHODS
Two thousand and seventy seven patients who underwent
a resection for colorectal cancer between 1 January 1991 and
31 December 1994 in 11 hospitals in the central belt of
Scotland were included in the study. Information was abstracted
from casenotes by two specially trained data managers. Details
included age, sex, deprivation category, site of tumour, extent
of tumour spread, Dukes’ stage, the nature of surgery, post-
operative mortality, and adjuvant therapy. Data for 1991 and 1992
were collected retrospectively, and those for 1993 and 1994 were
collected prospectively. There was no difference in baseline
characteristics of the patients between the two periods.
The extent of deprivation was defined using the Carstairs
Index (Carstairs and Morris, 1991), an area-based measure derived
from the 1991 census data based on the postcode of residents
at diagnosis. Carstairs divides the scores into a seven-point
scale ranging from most affluent (category 1) to most deprived
(category 7).
Tumours were classified according to site. The extent of tumour
spread was assessed by conventional Dukes’ classification based on
histological examination of the resected specimen.
Patients were deemed to have had a curative resection if the
surgeon considered that there was no macroscopic residual
tumour once resection had been completed.
Individual surgeons were defined as specialists or non-
specialists by a panel of six senior consultants and one of the
authors (CS McArdle). These assessments were carried out without
knowledge of the outcome and before any analysis was performed.
Approval was obtained for information on date and cause of
death to be checked with that received by the cancer registration
system through linkage with the Registrar General (Scotland).
Deaths up to the end of 2003 have been included in the analysis,
providing an average length of follow-up of 11 years (minimum
9 years, maximum 13 years).
Statistical analysis
The percentages of patients surviving 10 years were calculated
using the Kaplan–Meier technique. Comparison of the association
between age and other variables was carried out using the w
2-test
or a w
2 for trend where appropriate. The effect of age on cancer-
and non-cancer-related survival was examined using Cox’s
proportional hazards model. Analysis was performed using the
SPSS software package (SPSS Inc., Chicago, IL, USA).
RESULTS
Of the 2077 patients included in the analysis, 3% were aged less
than 45 years, 54% were male, 20% were socioeconomically
deprived, 63% had colonic tumours, and 49% had Dukes’ A/B
Table 1 Baseline characteristics and outcome at 10 years of patients undergoing surgery for colorectal cancer by age (n¼2077)
Age (years)
o45 years, 45–54 years, 55–64 years, 65–74 years,
n¼99 (3%) n¼223 (11%) n¼662 (32%) n¼1093 (53%) P-value
Female 47 (47%) 110 (49%) 304 (46%) 499 (46%)
Male 52 (53%) 113 (51%) 358 (54%) 594 (54%) 0.779
Depcat score
1, 2 11 (11%) 38 (17%) 138 (21%) 179 (16%)
3, 4, 5 68 (70%) 135 (61%) 403 (61%) 681 (62%)
6, 7 18 (19%) 49 (22%) 120 (18%) 232 (21%) 0.651
Mode of presentation
Elective 66 (67%) 151 (68%) 478 (72%) 809 (74%)
Emergency 33 (33%) 72 (32%) 184 (28%) 284 (26%) 0.023
Site
Right 23 (23%) 54 (24%) 144 (22%) 286 (26%)
Left 22 (22%) 28 (13%) 95 (14%) 168 (15%)
Sigmoid 15 (15%) 57 (26%) 157 (24%) 240 (22%)
Rectum 37 (37%) 81 (36%) 258 (39%) 389 (36%) 0.134
Dukes’ stage
A 6 (6%) 12 (5%) 39 (6%) 85 (8%)
B 30 (30%) 92 (41%) 282 (42%) 480 (44%)
C 37 (37%) 77 (35%) 197 (30%) 314 (29%)
D 26 (26%) 42 (19%) 144 (22%) 214 (20%) 0.008
Specialisation
Specialist 28 (29%) 44 (20%) 158 (25%) 259 (24%)
Non-specialist 67 (71%) 173 (80%) 486 (76%) 808 (76%) 0.974
10-year outcome
Alive 43 (43%) 98 (44%) 222 (34%) 279 (26%)
Cancer death 53 (53%) 116 (52%) 363 (55%) 534 (49%)
Non-cancer death 3 (3%) 9 (4%) 77 (12%) 280 (26%) o0.001
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sdisease at the time of surgery. A total of 489 (24%) patients were
treated by a specialist surgeon. Four percent of patients received
adjuvant therapy.
The baseline characteristics of the patients included in the study
are shown in Table 1. With young age there was an increase in the
proportion of patients who presented as an emergency (Po0.05),
who had node-positive disease (Po0.01) and died of their cancer.
A total of 1066 patients died of their cancer and 369 died of non-
cancer-related causes. Of the non-cancer-related deaths, 213 (58%)
patients died of cardiovascular or respiratory disease. At 10 years,
overall survival was 32%, cancer-specific was 45%, and non-cancer
related survival was 72%.
On univariate analysis, sex (Po0.001), mode of presentation
(Po0.001), Dukes’ stage (Po0.001), and specialisation (Po0.01)
were significantly associated with cancer-specific survival(Table 2).
On multivariate analysis of all factors, sex (hazard ratio (HR) 0.77,
95% CI 0.68–0.88, Po0.001), mode of presentation (HR 1.64, 95%
CI 1.44–1.87, Po0.01), Dukes’ stage (HR 2.69, 95% CI 2.49–2.90,
Po0.001), and specialisation (HR 1.24, 95% CI 1.04–1.44, Po0.01)
were independently associated with cancer-specific survival. When
age was entered into the multivariate model as a continuous
variable, it remained a nonsignificant predictor of cancer-specific
survival (P¼0.275).
On univariate analysis, age (Po0.001), sex (Po0.001), and
deprivation (Po0.001) were significantly associated with non-
cancer-related survival (Table 3). On multivariate analysis of
all factors, age (HR 2.46, 2.04–2.97, Po0.001), sex (HR 0.56,
0.45–0.70, Po0.001), and deprivation (HR 1.16, 1.10–1.24,
Po0.001) were independently associated with non-cancer-related
survival. When age was entered into the multivariate model as a
continuous variable, it remained a significant predictor of non-
cancer-related survival (HR 1.09, 95% CI 1.07–1.11, Po0.001).
The relationship between age and the HRs and survival rates for
cancer- and non-cancer-related survival is shown in Table 4.
Compared with patients under the age of 45 years, those patients
who were 45 years or over had no significant difference in their
HRs for cancer-specific survival. Compared with patients under
the age of 45years, those patients who were 45 years or over had a
progressive increase in their HRs (decrease in survival rate) for
non-cancer-related survival (Po0.001).
DISCUSSION
The results of this study show that, in patients undergoing
resection for colorectal cancer, excluding those of 75 years and
over and with 10-year follow-up, more young patients presented as
an emergency, had metastatic disease and died of their cancer than
of non-cancer-related causes. However, when adjusted for mode of
presentation and stage, there was no longer a significant relation-
ship between young age and poorer cancer-specific survival. In
contrast, young age was associated, independent of the above
factors, with a significant reduction in non-cancer-related survival.
Therefore, young age does not appear to have detrimental effect on
colorectal cancer outcomes.
There may be a danger that, if only patients undergoing curative
resection were included in the analysis, the survival rate of young
patients may be overestimated. However, in this study approxi-
mately 20% of patient had Dukes’ D disease. Therefore, the present
results are consistent with previous studies, which examined the
effect of young age on cancer-specific survival in patients with
colorectal cancer (Bu ¨low, 1980; Ja ¨rvinen and Turunen, 1984;
Isbister and Fraser, 1990; Cusack et al, 1996; Chung et al, 1998;
O’Connell et al, 2004; Quah et al, 2007).
A limitation of this study is that the data collection was in part
retrospective. However, few studies have examined the relation-
ship between young age and non-cancer survival and only one with
10-year follow-up. Leff et al (2007) identified 49 patients aged of
Table 2 The relationship between clinicopathological characteristics and cancer-specific survival in patients undergoing surgery for colorectal cancer:
univariate and multivariate analysis
Univariate analysis Multivariate analysis
Patients (n¼2077) Hazard ratio (95% CI) P-value Hazard ratio (95% CI) P-value
Age (o45/45–54/55–64/65–74 years) 99/223/662/1093 1.00 (0.93–1.07) 0.972 0.258
Sex (female/male) 960/1117 0.77 (0.68–0.87) o0.001 0.77 (0.68–0.88) o0.001
Deprivation (1–2/3–5/6–7)
a 366/1287/419 1.01 (0.78–1.05) 0.512 0.931
Mode of presentation (elective/emergency) 1504/573 1.66 (1.46–1.89) o0.001 1.64 (1.44–1.87) o0.001
Site (right/left/sigmoid/rectum) 507/313/469/765 1.01 (0.96–1.05) 0.757 0.227
Dukes’ stage (A/B/C/D) 142/884/625/426 2.68 (2.49–2.90) o0.001 2.69 (2.49–2.90) o0.001
Specialisation (yes/no) 489/1534 1.22 (1.05–1.42) 0.009 1.24 (1.04–1.44) 0.005
Abbreviation: CI¼confidence interval.
aIndividual deprivation categories were used in the statistical analysis.
Table 3 The relationship between clinicopathological characteristics and non-cancer-related survival in patients undergoing surgery for colorectal cancer:
univariate and multivariate analysis
Univariate analysis Multivariate analysis
Patients (n¼2077) Hazard ratio (95% CI) P-value Hazard ratio (95% CI) P-value
Age (o45/45–54/55–64/65–74 years) 99/223/662/1093 2.52 (2.09–3.04) o0.001 2.46 (2.04–2.97) o0.001
Sex (female/male) 960/1117 0.56 (0.46–0.70) o0.001 0.56 (0.45–0.70) o0.001
Deprivation (1–2/3–5/6–7)
a 366/1287/419 1.16 (1.09–1.23) o0.001 1.16 (1.10–1.24) o0.001
Mode of presentation (elective/emergency) 1504/573 1.09 (0.85–1.38) 0.504 0.324
Site (right/left/sigmoid/rectum) 507/313/469/765 1.06 (0.98–1.14) 0.136 0.140
Dukes’ stage (A/B/C/D) 142/884/625/426 1.10 (0.96–1.25) 0.194 0.067
Specialisation (yes/no) 489/1534 0.90 (0.72–1.14) 0.376 0.659
Abbreviation: CI¼confidence interval.
aIndividual deprivation categories were used in the statistical analysis.
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s40 years or less at St Marks Hospital between 1982 and 1992 and
reported that 10-year overall survival rate was 46%. In this study
of 99 patients under the age of 45 years, the 10-year overall survival
rate was similar at 43%. However, the overall survival rate was
dominated by a cancer-specific survival rate of 46% and the
non-cancer survival rate was 95% at 10 years.
The results of this study have a number of important
implications. First, patients who develop colorectal cancer at a
young age are unlikely to require treatment over and above routine
care. Second, if cured from their disease, their lifespan, certainly at
10 years, is unlikely to be altered by their diagnosis with colorectal
cancer. Also, as young patients are more likely to present as an
emergency or with metastatic disease, it may be that there are
delays in the treatment of these young patients in the health-care
system, as these patients would not be normally considered at risk
of colorectal cancer. Therefore, it remains important that young
patients presenting with symptoms suggestive of colorectal cancer
are investigated thoroughly.
In summary, the results of this study confirm that young age
does not have a negative impact on cancer-specific survival.
Moreover, they show that, with 10-year follow-up, young age does
not have a negative impact on non-cancer-related survival.
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